The First Humanoid Robot Surgery Is Here

A five-foot humanoid robot just removed a gallbladder in live surgery, and both parties in America’s broken system now have a new question: will the next person holding the scalpel answer to patients—or to the people who own the robots?

Story Snapshot

Teleoperated humanoid robots completed the first live gallbladder removals in animals, a “world first” step toward human trials.
One operation used a human-robot team; the other used two robots working together with no human at the bedside.
The compact robot, nicknamed “Surgie,” is designed to fit into normal operating rooms and could be run remotely to reach rural or poor communities.
The trial was successful but tiny—only two pig surgeries—and the system is far from approved for human patients.

What Actually Happened in the Operating Room

Researchers at the University of California San Diego say they have, for the first time, used teleoperated humanoid robots to complete live gallbladder removal surgeries in large animals. The peer-reviewed study in the journal Nature describes two laparoscopic cholecystectomies—standard keyhole gallbladder procedures—performed on pigs using a compact humanoid robot system. In one surgery, a human surgeon stood at the bedside as an assistant while the robot did the main work. In the other, two humanoid robots operated side by side with no human physically at the table.

The robot, nicknamed “Surgie,” is roughly five feet tall, with human-like arms sized for the tight space around an operating table. A surgeon controlled the robot at a console, similar to how doctors already use the well-known da Vinci robotic system, but without the giant, room-filling base. Video and reports say Surgie cleanly separated the gallbladder from the liver and cauterized tissue, completing the operations without major complications in this early test. One surgeon described it simply: “As a proof of concept, it absolutely worked.”

How This Differs from Earlier Robot Surgery Hype

For years, headlines have promised robot doctors, but most systems have been either clumsy industrial arms or huge, expensive platforms that only rich hospitals can buy. Earlier breakthroughs focused on robots working on cadavers or lifelike models, or on small parts of a procedure. This trial is different in two ways: the robot is humanoid and sized like a person, and the surgeries were live operations inside an actual animal body, not a plastic training model. That is why UC San Diego and many outlets are calling it a “world first.”

Humanoid form matters because it is meant to walk into a normal operating room and use tools already there, instead of forcing hospitals to rebuild space around one giant device. Researchers say a humanoid robot like Surgie could one day assist with surgery, move equipment, or even clean and restock rooms between cases. That flexible, multi-purpose role is appealing to hospital executives facing staff shortages and rising costs—but it also raises fears about which human jobs disappear first.

Big Promises: Remote Surgery and Rural Patients

The UC San Diego team says their long-term goal is remote surgery, where a skilled surgeon in a city could operate on a patient in a small town hundreds of miles away. Because Surgie is compact and relatively light, the robot could, in theory, be shipped to under-served clinics or even conflict zones while the human expert stays in a safe, well-equipped hub. For Americans who watch both parties fail to fix rural hospital closures, that promise is powerful: real specialty care without having to drive hours or go into crushing debt.

Incredible robotics resarch award of the day goes to: UC San Diego for performing surgery on a live pig using a humanoid robot (Unitree G1).

Accuracy of this approach is indistinguishable to using a da Vinci surgery robots worth several millions of dollars.
Only caveat: 2x… pic.twitter.com/1d3W7hjm0q

— Léo (@LeoKharon) July 10, 2026

At the same time, many on both the right and the left already feel the health system treats them like billing codes, not people. They see insurers delay care, drug companies push prices up, and hospital chains swallow local clinics. A robot in the operating room could either be a lifeline—or the next way the “elites” squeeze more profit out of patients while hiding behind high-tech buzzwords.

Limits, Risks, and the Gap to Human Trials

Despite the hype, the study is tiny: just two pig surgeries. That is enough to show that the idea can work, but nowhere near enough to prove it is safe, reliable, or better than what we have now. Researchers themselves call this a preclinical trial and a proof of concept, not a human-ready system. One of the two surgeries still needed a human assistant at the bedside to adjust the robot’s arms, which shows it cannot yet operate fully on its own in every setup.

Moving from animals to people means years of testing under frameworks like the IDEAL guidelines, which set step-by-step stages for new surgical devices, from lab tests to controlled human trials. The Food and Drug Administration (FDA) will demand detailed data on errors, complications, and even software failures. History suggests that most flashy new surgical robots never make it through this gauntlet, and those that do often end up used in ways that pad hospital marketing more than they transform everyday care.

Who Really Wins if Robot Surgeons Take Off?

Supporters argue that if humanoid robots can spread skilled surgery to poor, rural, or overcrowded areas, that would be a rare win for ordinary Americans on both sides of the aisle. They also note that robotic and artificial intelligence–assisted surgeries, when done well, have already shown fewer complications and shorter operating times in some cases. For patients stuck between understaffed hospitals and sky-high bills, more precise, less risky operations sound like common sense, not ideology.

But many readers will ask harder questions: Who owns the robots and the software? Will savings go to lower patient bills, or to hospital chains, insurers, and tech investors? If something goes wrong, will anyone accept blame, or will a maze of companies and agencies point fingers at each other? In a country where trust in government, big business, and “the experts” has sunk so low, a humanoid holding a scalpel in a room full of people worried about their jobs and their families will not feel like progress unless the system around it changes too.